Aviceda to Advance GA Drug into Phase III Trials Despite Phase IIb Primary Endpoint Miss
Lesions aside, functional vision keeps AVD-104 in the GA therapy race. In geographic atrophy (GA) drug development, a missed primary…
When Manila Meets Macula: Highlights from Day 1 at APVRS 2025
Retina, culture and a cup of taho. APVRS 2025 in Manila kicks off in style. Mabuhay from Manila, and welcome…
popular posts
latest posts
